<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-24" modified="2018-01-31" version="190">
<accession>Q07912</accession>
<accession>Q6ZMQ0</accession>
<accession>Q8N6U7</accession>
<accession>Q96H59</accession>
<name>ACK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Activated CDC42 kinase 1</fullName>
<shortName>ACK-1</shortName>
<ecNumber evidence="15 21 23 30 34">2.7.10.2</ecNumber>
<ecNumber evidence="21 30">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Tyrosine kinase non-receptor protein 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TNK2</name>
<name type="synonym">ACK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Nature" volume="363" first="364" last="367">
<title>A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42.</title>
<authorList>
<person name="Manser E."/>
<person name="Leung T."/>
<person name="Salihuddin H."/>
<person name="Tan L."/>
<person name="Lim L."/>
</authorList>
<dbReference type="PubMed" id="8497321"/>
<dbReference type="DOI" id="10.1038/363364a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH CDC42</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<scope>VARIANT LEU-725</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Nat. Cell Biol." volume="1" first="507" last="513">
<title>Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.</title>
<authorList>
<person name="Eisenmann K.M."/>
<person name="McCarthy J.B."/>
<person name="Simpson M.A."/>
<person name="Keely P.J."/>
<person name="Guan J.-L."/>
<person name="Tachibana K."/>
<person name="Lim L."/>
<person name="Manser E."/>
<person name="Furcht L.T."/>
<person name="Iida J."/>
</authorList>
<dbReference type="PubMed" id="10587647"/>
<dbReference type="DOI" id="10.1038/70302"/>
</citation>
<scope>INTERACTION WITH CSPG4</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="268" first="141" last="147">
<title>Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation.</title>
<authorList>
<person name="Kato J."/>
<person name="Kaziro Y."/>
<person name="Satoh T."/>
</authorList>
<dbReference type="PubMed" id="10652228"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.2106"/>
</citation>
<scope>FUNCTION AS MCF2 KINASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="18392" last="18398">
<title>The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors.</title>
<authorList>
<person name="Teo M."/>
<person name="Tan L."/>
<person name="Lim L."/>
<person name="Manser E."/>
</authorList>
<dbReference type="PubMed" id="11278436"/>
<dbReference type="DOI" id="10.1074/jbc.M008795200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="314" first="571" last="579">
<title>Cdc42-dependent nuclear translocation of non-receptor tyrosine kinase, ACK.</title>
<authorList>
<person name="Ahmed I."/>
<person name="Calle Y."/>
<person name="Sayed M.A."/>
<person name="Kamal J.M."/>
<person name="Rengaswamy P."/>
<person name="Manser E."/>
<person name="Meiners S."/>
<person name="Nur-E-Kamal A."/>
</authorList>
<dbReference type="PubMed" id="14733946"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.12.137"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="10514" last="10523">
<title>Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.</title>
<authorList>
<person name="Mahajan N.P."/>
<person name="Whang Y.E."/>
<person name="Mohler J.L."/>
<person name="Earp H.S."/>
</authorList>
<dbReference type="PubMed" id="16288044"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-1127"/>
</citation>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH HSP90AB1; MTERK AND WWOX</scope>
<scope>MUTAGENESIS OF LYS-158 AND LEU-487</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="5040" last="5048">
<title>SNX9 as an adaptor for linking synaptojanin-1 to the Cdc42 effector ACK1.</title>
<authorList>
<person name="Yeow-Fong L."/>
<person name="Lim L."/>
<person name="Manser E."/>
</authorList>
<dbReference type="PubMed" id="16137687"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.07.093"/>
</citation>
<scope>INTERACTION WITH SNX9</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="42219" last="42226">
<title>Phosphorylation of WASP by the Cdc42-associated kinase ACK1: dual hydroxyamino acid specificity in a tyrosine kinase.</title>
<authorList>
<person name="Yokoyama N."/>
<person name="Lougheed J."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="16257963"/>
<dbReference type="DOI" id="10.1074/jbc.M506996200"/>
</citation>
<scope>FUNCTION AS WAS KINASE</scope>
<scope>INTERACTION WITH WASL</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="15901" last="15906">
<title>Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.</title>
<authorList>
<person name="van der Horst E.H."/>
<person name="Degenhardt Y.Y."/>
<person name="Strelow A."/>
<person name="Slavin A."/>
<person name="Chinn L."/>
<person name="Orf J."/>
<person name="Rong M."/>
<person name="Li S."/>
<person name="See L.-H."/>
<person name="Nguyen K.Q.C."/>
<person name="Hoey T."/>
<person name="Wesche H."/>
<person name="Powers S."/>
</authorList>
<dbReference type="PubMed" id="16247015"/>
<dbReference type="DOI" id="10.1073/pnas.0508014102"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="37527" last="37535">
<title>Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas.</title>
<authorList>
<person name="Modzelewska K."/>
<person name="Newman L.P."/>
<person name="Desai R."/>
<person name="Keely P.J."/>
</authorList>
<dbReference type="PubMed" id="17038317"/>
<dbReference type="DOI" id="10.1074/jbc.M604342200"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>INTERACTION WITH BCAR1; CDC42 AND CRK</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Methods Enzymol." volume="406" first="250" last="260">
<title>Purification and enzyme activity of ACK1.</title>
<authorList>
<person name="Yokoyama N."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="16472662"/>
<dbReference type="DOI" id="10.1016/S0076-6879(06)06018-6"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-284</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="8438" last="8443">
<title>Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.</title>
<authorList>
<person name="Mahajan N.P."/>
<person name="Liu Y."/>
<person name="Majumder S."/>
<person name="Warren M.R."/>
<person name="Parker C.E."/>
<person name="Mohler J.L."/>
<person name="Earp H.S."/>
<person name="Whang Y.E."/>
</authorList>
<dbReference type="PubMed" id="17494760"/>
<dbReference type="DOI" id="10.1073/pnas.0700420104"/>
</citation>
<scope>INTERACTION WITH AR</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="371" first="877" last="882">
<title>Nephrocystin-1 interacts directly with Ack1 and is expressed in human collecting duct.</title>
<authorList>
<person name="Eley L."/>
<person name="Moochhala S.H."/>
<person name="Simms R."/>
<person name="Hildebrandt F."/>
<person name="Sayer J.A."/>
</authorList>
<dbReference type="PubMed" id="18477472"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.05.016"/>
</citation>
<scope>INTERACTION WITH NPHP1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Breast Cancer Res." volume="10" first="R36" last="R36">
<title>TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.</title>
<authorList>
<person name="Howlin J."/>
<person name="Rosenkvist J."/>
<person name="Andersson T."/>
</authorList>
<dbReference type="PubMed" id="18435854"/>
<dbReference type="DOI" id="10.1186/bcr2087"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Exp. Cell Res." volume="314" first="1292" last="1300">
<title>Dysregulation of Ack1 inhibits down-regulation of the EGF receptor.</title>
<authorList>
<person name="Groevdal L.M."/>
<person name="Johannessen L.E."/>
<person name="Roedland M.S."/>
<person name="Madshus I.H."/>
<person name="Stang E."/>
</authorList>
<dbReference type="PubMed" id="18262180"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2007.12.017"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-881</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="8185" last="8194">
<title>Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.</title>
<authorList>
<person name="Chan W."/>
<person name="Tian R."/>
<person name="Lee Y.-F."/>
<person name="Sit S.T."/>
<person name="Lim L."/>
<person name="Manser E."/>
</authorList>
<dbReference type="PubMed" id="19144635"/>
<dbReference type="DOI" id="10.1074/jbc.M806877200"/>
</citation>
<scope>INTERACTION WITH NEDD4</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="34954" last="34963">
<title>Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.</title>
<authorList>
<person name="Pao-Chun L."/>
<person name="Chan P.M."/>
<person name="Chan W."/>
<person name="Manser E."/>
</authorList>
<dbReference type="PubMed" id="19815557"/>
<dbReference type="DOI" id="10.1074/jbc.M109.072660"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AXL; LTK; PDGFRL AND GRB2</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-284 AND SER-724</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="BMC Biochem." volume="11" first="42" last="42">
<title>Regulation of Ack1 localization and activity by the amino-terminal SAM domain.</title>
<authorList>
<person name="Prieto-Echaguee V."/>
<person name="Gucwa A."/>
<person name="Brown D.A."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="20979614"/>
<dbReference type="DOI" id="10.1186/1471-2091-11-42"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-284</scope>
<scope>DOMAIN SAM-LIKE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="10605" last="10615">
<title>Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1.</title>
<authorList>
<person name="Prieto-Echaguee V."/>
<person name="Gucwa A."/>
<person name="Craddock B.P."/>
<person name="Brown D.A."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="20110370"/>
<dbReference type="DOI" id="10.1074/jbc.M109.060459"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS LEU-34; GLN-99; LYS-346 AND ILE-409</scope>
<scope>CHARACTERIZATION OF VARIANTS LEU-34; GLN-99; LYS-346 AND ILE-409</scope>
<scope>MUTAGENESIS OF LEU-120; LEU-197 AND VAL-365</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="3208" last="3216">
<title>Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.</title>
<authorList>
<person name="Liu Y."/>
<person name="Karaca M."/>
<person name="Zhang Z."/>
<person name="Gioeli D."/>
<person name="Earp H.S."/>
<person name="Whang Y.E."/>
</authorList>
<dbReference type="PubMed" id="20383201"/>
<dbReference type="DOI" id="10.1038/onc.2010.103"/>
</citation>
<scope>FUNCTION AS AR KINASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9646" last="E9646">
<title>Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.</title>
<authorList>
<person name="Mahajan K."/>
<person name="Coppola D."/>
<person name="Challa S."/>
<person name="Fang B."/>
<person name="Chen Y.A."/>
<person name="Zhu W."/>
<person name="Lopez A.S."/>
<person name="Koomen J."/>
<person name="Engelman R.W."/>
<person name="Rivera C."/>
<person name="Muraoka-Cook R.S."/>
<person name="Cheng J.Q."/>
<person name="Schoenbrunn E."/>
<person name="Sebti S.M."/>
<person name="Earp H.S."/>
<person name="Mahajan N.P."/>
</authorList>
<dbReference type="PubMed" id="20333297"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009646"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>INTERACTION WITH AKT1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT LYS-346</scope>
<scope>PHOSPHORYLATION AT TYR-284</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Prostate" volume="70" first="1274" last="1285">
<title>Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.</title>
<authorList>
<person name="Mahajan K."/>
<person name="Challa S."/>
<person name="Coppola D."/>
<person name="Lawrence H."/>
<person name="Luo Y."/>
<person name="Gevariya H."/>
<person name="Zhu W."/>
<person name="Chen Y.A."/>
<person name="Lawrence N.J."/>
<person name="Mahajan N.P."/>
</authorList>
<dbReference type="PubMed" id="20623637"/>
<dbReference type="DOI" id="10.1002/pros.21163"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-284</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Biochem. J." volume="435" first="355" last="364">
<title>The Cdc42-associated kinase ACK1 is not auto-inhibited but requires Src for activation.</title>
<authorList>
<person name="Chan W."/>
<person name="Sit S.T."/>
<person name="Manser E."/>
</authorList>
<dbReference type="PubMed" id="21309750"/>
<dbReference type="DOI" id="10.1042/BJ20102156"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-284</scope>
<scope>INTERACTION WITH SRC</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Mol. Biol. Cell" volume="22" first="493" last="502">
<title>Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at arrested endocytic clathrin-coated pits of cells that lack dynamin.</title>
<authorList>
<person name="Shen H."/>
<person name="Ferguson S.M."/>
<person name="Dephoure N."/>
<person name="Park R."/>
<person name="Yang Y."/>
<person name="Volpicelli-Daley L."/>
<person name="Gygi S."/>
<person name="Schlessinger J."/>
<person name="De Camilli P."/>
</authorList>
<dbReference type="PubMed" id="21169560"/>
<dbReference type="DOI" id="10.1091/mbc.E10-07-0637"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-284; TYR-518; TYR-827; TYR-859 AND TYR-872</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="J. Cell. Physiol." volume="224" first="327" last="333">
<title>Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.</title>
<authorList>
<person name="Mahajan K."/>
<person name="Mahajan N.P."/>
</authorList>
<dbReference type="PubMed" id="20432460"/>
<dbReference type="DOI" id="10.1002/jcp.22162"/>
</citation>
<scope>REVIEW ON TUMOR GROWTH</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="Nature" volume="399" first="384" last="388">
<title>Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK.</title>
<authorList>
<person name="Mott H.R."/>
<person name="Owen D."/>
<person name="Nietlispach D."/>
<person name="Lowe P.N."/>
<person name="Manser E."/>
<person name="Lim L."/>
<person name="Laue E.D."/>
</authorList>
<dbReference type="PubMed" id="10360579"/>
<dbReference type="DOI" id="10.1038/20732"/>
</citation>
<scope>STRUCTURE BY NMR OF 448-489</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="44039" last="44045">
<title>Crystal structures of the phosphorylated and unphosphorylated kinase domains of the Cdc42-associated tyrosine kinase ACK1.</title>
<authorList>
<person name="Lougheed J.C."/>
<person name="Chen R.-H."/>
<person name="Mak P."/>
<person name="Stout T.J."/>
</authorList>
<dbReference type="PubMed" id="15308621"/>
<dbReference type="DOI" id="10.1074/jbc.M406703200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 107-395</scope>
<scope>PHOSPHORYLATION AT TYR-284</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Bioorg. Med. Chem. Lett." volume="18" first="6352" last="6356">
<title>Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.</title>
<authorList>
<person name="Kopecky D.J."/>
<person name="Hao X."/>
<person name="Chen Y."/>
<person name="Fu J."/>
<person name="Jiao X."/>
<person name="Jaen J.C."/>
<person name="Cardozo M.G."/>
<person name="Liu J."/>
<person name="Wang Z."/>
<person name="Walker N.P."/>
<person name="Wesche H."/>
<person name="Li S."/>
<person name="Farrelly E."/>
<person name="Xiao S.H."/>
<person name="Kayser F."/>
</authorList>
<dbReference type="PubMed" id="18993068"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2008.10.092"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 117-392 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS LEU-34; ARG-71; GLN-99; TRP-99; MET-152; LYS-346; ILE-409; SER-507; LEU-725; GLN-748 AND HIS-1038</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="Ann. Neurol." volume="74" first="496" last="501">
<title>Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy.</title>
<authorList>
<person name="Hitomi Y."/>
<person name="Heinzen E.L."/>
<person name="Donatello S."/>
<person name="Dahl H.H."/>
<person name="Damiano J.A."/>
<person name="McMahon J.M."/>
<person name="Berkovic S.F."/>
<person name="Scheffer I.E."/>
<person name="Legros B."/>
<person name="Rai M."/>
<person name="Weckhuysen S."/>
<person name="Suls A."/>
<person name="De Jonghe P."/>
<person name="Pandolfo M."/>
<person name="Goldstein D.B."/>
<person name="Van Bogaert P."/>
<person name="Depondt C."/>
</authorList>
<dbReference type="PubMed" id="23686771"/>
<dbReference type="DOI" id="10.1002/ana.23934"/>
</citation>
<scope>VARIANT MET-638</scope>
<scope>INTERACTION WITH NEDD4 AND NEDD4L</scope>
<scope>CHARACTERIZATION OF VARIANT MET-638</scope>
</reference>
<comment type="function">
<text evidence="15 16 20 21 23 24 27 28 32 33 34 35">Non-receptor tyrosine-protein and serine/threonine-protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR, thereby contributing to the accumulation of EGFR at the limiting membrane of early endosomes. Downstream effector of CDC42 which mediates CDC42-dependent cell migration via phosphorylation of BCAR1. May be involved both in adult synaptic function and plasticity and in brain development. Activates AKT1 by phosphorylating it on 'Tyr-176'. Phosphorylates AR on 'Tyr-267' and 'Tyr-363' thereby promoting its recruitment to androgen-responsive enhancers (AREs). Phosphorylates WWOX on 'Tyr-287'. Phosphorylates MCF2, thereby enhancing its activity as a guanine nucleotide exchange factor (GEF) toward Rho family proteins. Contributes to the control of AXL receptor levels. Confers metastatic properties on cancer cells and promotes tumor growth by negatively regulating tumor suppressor such as WWOX and positively regulating pro-survival factors such as AKT1 and AR. Phosphorylates WASP (PubMed:20110370).</text>
</comment>
<comment type="catalytic activity">
<text evidence="13 15 21 23 30 34">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="catalytic activity">
<text evidence="21 30">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="15 21 34">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="35 36">Inhibited by AIM-100 (4-amino-5,6-biaryl-furo[2,3-d]pyrimidine), which suppresses activating phosphorylation at Tyr-284. Repressed by dasatinib.</text>
</comment>
<comment type="subunit">
<text evidence="9 14 19 21 22 24 26 29 30 31 32 34 37 39 40 41">Interacts with NEDD4 (via WW3 domain). NEDD4L and EGF promote association with NEDD4 (By similarity). Homodimer. Interacts with AR, CDC42, WWASL and WWOX. Interacts with CSPG4 (activated). Interacts with MERTK (activated); stimulates autophosphorylation. May interact (phosphorylated) with HSP90AB1; maintains kinase activity. Interacts with NPHP1. Interacts with SNX9 (via SH3 domain). Interacts with SRC (via SH2 and SH3 domain). Interacts with EGFR, and this interaction is dependent on EGF stimulation and kinase activity of EGFR. Interacts (via kinase domain) with AKT1. Part of a collagen stimulated complex involved in cell migration composed of CDC42, CRK, TNK2 and BCAR1/p130cas. Interacts with BCAR1/p130cas via SH3 domains. Forms complexes with GRB2 and numerous receptor tyrosine kinases (RTK) including LTK, AXL or PDGFRL, in which GRB2 promotes RTK recruitment by TNK2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-603457"/>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-745213">
<id>P29972</id>
<label>AQP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-702093">
<id>P56945</id>
<label>BCAR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-287394">
<id>P60953-2</id>
<label>CDC42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-354967">
<id>Q00610</id>
<label>CLTC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11994780"/>
<interactant intactId="EBI-750827">
<id>P07902</id>
<label>GALT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-740364">
<id>Q9HC98</id>
<label>NEK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-945833">
<id>Q7Z3S9</id>
<label>NOTCH2NL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-603457"/>
<interactant intactId="EBI-6983382">
<id>O60880</id>
<label>SH2D1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell junction</location>
<location evidence="9">adherens junction</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle membrane</location>
<topology>Peripheral membrane protein</topology>
<orientation>Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
<location>clathrin-coated vesicle</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<location>clathrin-coated pit</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="33">Cytoplasm</location>
<location evidence="33">perinuclear region</location>
</subcellularLocation>
<text>The Tyr-284 phosphorylated form is found both in the membrane and nucleus. Colocalizes with EGFR on endosomes. Nuclear translocation is CDC42-dependent.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q07912-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q07912-2</id>
<name>2</name>
<sequence type="described" ref="VSP_008655 VSP_008656"/>
<text>No experimental confirmation available. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>Q07912-3</id>
<name>3</name>
<sequence type="described" ref="VSP_037284 VSP_037285 VSP_037286"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="20 34 36">The Tyr-284 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. It also shows a significant increase in expression in prostate cancers during the progressive stages.</text>
</comment>
<comment type="domain">
<text evidence="9">The EBD (EGFR-binding domain) domain is necessary for interaction with EGFR.</text>
</comment>
<comment type="domain">
<text evidence="37">The SAM-like domain is necessary for NEDD4-mediated ubiquitination. Promotes membrane localization and dimerization to allow for autophosphorylation.</text>
</comment>
<comment type="domain">
<text evidence="37">The UBA domain binds both poly- and mono-ubiquitin.</text>
</comment>
<comment type="PTM">
<text evidence="18 23 34 36 37 38 39">Autophosphorylation regulates kinase activity. Phosphorylation on Tyr-518 is required for interaction with SRC and is observed during association with clathrin-coated pits.</text>
</comment>
<comment type="PTM">
<text evidence="9">Polyubiquitinated by NEDD4 and NEDD4L. Degradation can be induced by EGF and is lysosome-dependent (By similarity).</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the protein kinase superfamily. Tyr protein kinase family.</text>
</comment>
<comment type="sequence caution" evidence="44">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH08884" version="1"/>
</conflict>
<text>Unlikely isoform. Aberrant splice sites.</text>
</comment>
<dbReference type="EC" id="2.7.10.2" evidence="15 21 23 30 34"/>
<dbReference type="EC" id="2.7.11.1" evidence="21 30"/>
<dbReference type="EMBL" id="L13738">
<property type="protein sequence ID" value="AAA53570.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK131539">
<property type="protein sequence ID" value="BAD18675.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC124944">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008884">
<property type="protein sequence ID" value="AAH08884.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028164">
<property type="protein sequence ID" value="AAH28164.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33927.1">
<molecule id="Q07912-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33928.1">
<molecule id="Q07912-1"/>
</dbReference>
<dbReference type="PIR" id="S33596">
<property type="entry name" value="S33596"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001010938.1">
<molecule id="Q07912-3"/>
<property type="nucleotide sequence ID" value="NM_001010938.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001294975.1">
<property type="nucleotide sequence ID" value="NM_001308046.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005772.3">
<molecule id="Q07912-1"/>
<property type="nucleotide sequence ID" value="NM_005781.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.518513"/>
<dbReference type="PDB" id="1CF4">
<property type="method" value="NMR"/>
<property type="chains" value="B=448-489"/>
</dbReference>
<dbReference type="PDB" id="1U46">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=109-395"/>
</dbReference>
<dbReference type="PDB" id="1U4D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=109-395"/>
</dbReference>
<dbReference type="PDB" id="1U54">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=109-395"/>
</dbReference>
<dbReference type="PDB" id="3EQP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=117-392"/>
</dbReference>
<dbReference type="PDB" id="3EQR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=117-392"/>
</dbReference>
<dbReference type="PDB" id="4EWH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=117-391"/>
</dbReference>
<dbReference type="PDB" id="4HZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.31"/>
<property type="chains" value="A/B=115-389"/>
</dbReference>
<dbReference type="PDB" id="4HZS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.23"/>
<property type="chains" value="A/B/C/D=115-453"/>
</dbReference>
<dbReference type="PDB" id="4ID7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=117-389"/>
</dbReference>
<dbReference type="PDBsum" id="1CF4"/>
<dbReference type="PDBsum" id="1U46"/>
<dbReference type="PDBsum" id="1U4D"/>
<dbReference type="PDBsum" id="1U54"/>
<dbReference type="PDBsum" id="3EQP"/>
<dbReference type="PDBsum" id="3EQR"/>
<dbReference type="PDBsum" id="4EWH"/>
<dbReference type="PDBsum" id="4HZR"/>
<dbReference type="PDBsum" id="4HZS"/>
<dbReference type="PDBsum" id="4ID7"/>
<dbReference type="ProteinModelPortal" id="Q07912"/>
<dbReference type="SMR" id="Q07912"/>
<dbReference type="BioGrid" id="115485">
<property type="interactions" value="78"/>
</dbReference>
<dbReference type="CORUM" id="Q07912"/>
<dbReference type="DIP" id="DIP-33858N"/>
<dbReference type="IntAct" id="Q07912">
<property type="interactions" value="37"/>
</dbReference>
<dbReference type="MINT" id="MINT-1382124"/>
<dbReference type="STRING" id="9606.ENSP00000371341"/>
<dbReference type="BindingDB" id="Q07912"/>
<dbReference type="ChEMBL" id="CHEMBL4599"/>
<dbReference type="DrugBank" id="DB00171">
<property type="generic name" value="Adenosine triphosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04367">
<property type="generic name" value="Debromohymenialdisine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2246"/>
<dbReference type="iPTMnet" id="Q07912"/>
<dbReference type="PhosphoSitePlus" id="Q07912"/>
<dbReference type="BioMuta" id="TNK2"/>
<dbReference type="DMDM" id="229462980"/>
<dbReference type="EPD" id="Q07912"/>
<dbReference type="MaxQB" id="Q07912"/>
<dbReference type="PaxDb" id="Q07912"/>
<dbReference type="PeptideAtlas" id="Q07912"/>
<dbReference type="PRIDE" id="Q07912"/>
<dbReference type="DNASU" id="10188"/>
<dbReference type="Ensembl" id="ENST00000333602">
<molecule id="Q07912-1"/>
<property type="protein sequence ID" value="ENSP00000329425"/>
<property type="gene ID" value="ENSG00000061938"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000381916">
<molecule id="Q07912-3"/>
<property type="protein sequence ID" value="ENSP00000371341"/>
<property type="gene ID" value="ENSG00000061938"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000439230">
<molecule id="Q07912-2"/>
<property type="protein sequence ID" value="ENSP00000395588"/>
<property type="gene ID" value="ENSG00000061938"/>
</dbReference>
<dbReference type="GeneID" id="10188"/>
<dbReference type="KEGG" id="hsa:10188"/>
<dbReference type="UCSC" id="uc003fvt.2">
<molecule id="Q07912-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10188"/>
<dbReference type="DisGeNET" id="10188"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000061938.16"/>
<dbReference type="GeneCards" id="TNK2"/>
<dbReference type="H-InvDB" id="HIX0003961"/>
<dbReference type="HGNC" id="HGNC:19297">
<property type="gene designation" value="TNK2"/>
</dbReference>
<dbReference type="HPA" id="HPA041954"/>
<dbReference type="MalaCards" id="TNK2"/>
<dbReference type="MIM" id="606994">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q07912"/>
<dbReference type="OpenTargets" id="ENSG00000061938"/>
<dbReference type="Orphanet" id="391316">
<property type="disease" value="Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134909759"/>
<dbReference type="eggNOG" id="KOG0199">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPRC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000168225"/>
<dbReference type="HOVERGEN" id="HBG100429"/>
<dbReference type="InParanoid" id="Q07912"/>
<dbReference type="KO" id="K08886"/>
<dbReference type="OMA" id="PQRGCPG"/>
<dbReference type="OrthoDB" id="EOG091G03HT"/>
<dbReference type="PhylomeDB" id="Q07912"/>
<dbReference type="TreeFam" id="TF316643"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="SignaLink" id="Q07912"/>
<dbReference type="SIGNOR" id="Q07912"/>
<dbReference type="ChiTaRS" id="TNK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q07912"/>
<dbReference type="GeneWiki" id="TNK2"/>
<dbReference type="GenomeRNAi" id="10188"/>
<dbReference type="PRO" id="PR:Q07912"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000061938"/>
<dbReference type="CleanEx" id="HS_TNK2"/>
<dbReference type="ExpressionAtlas" id="Q07912">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q07912">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005912">
<property type="term" value="C:adherens junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005905">
<property type="term" value="C:clathrin-coated pit"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030136">
<property type="term" value="C:clathrin-coated vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030659">
<property type="term" value="C:cytoplasmic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070436">
<property type="term" value="C:Grb2-EGFR complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005154">
<property type="term" value="F:epidermal growth factor receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005095">
<property type="term" value="F:GTPase inhibitor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050699">
<property type="term" value="F:WW domain binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006897">
<property type="term" value="P:endocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000369">
<property type="term" value="P:regulation of clathrin-dependent endocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007264">
<property type="term" value="P:small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.680.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR030220">
<property type="entry name" value="Ack1"/>
</dbReference>
<dbReference type="InterPro" id="IPR037085">
<property type="entry name" value="Cdc42-bd-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015116">
<property type="entry name" value="Cdc42_binding_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR021619">
<property type="entry name" value="Mig-6"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR14254:SF4">
<property type="entry name" value="PTHR14254:SF4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09027">
<property type="entry name" value="GTPase_binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11555">
<property type="entry name" value="Inhibitor_Mig-6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14604">
<property type="entry name" value="SH3_9"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0168">Coated pit</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Activated CDC42 kinase 1" id="PRO_0000088058">
<location>
<begin position="1"/>
<end position="1038"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="11">
<location>
<begin position="126"/>
<end position="385"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="12">
<location>
<begin position="388"/>
<end position="448"/>
</location>
</feature>
<feature type="domain" description="CRIB">
<location>
<begin position="454"/>
<end position="466"/>
</location>
</feature>
<feature type="domain" description="UBA">
<location>
<begin position="958"/>
<end position="996"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="132"/>
<end position="140"/>
</location>
</feature>
<feature type="region of interest" description="SAM-like domain">
<location>
<begin position="1"/>
<end position="110"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with SRC" evidence="39">
<location>
<begin position="623"/>
<end position="652"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with NEDD4" evidence="9">
<location>
<begin position="632"/>
<end position="635"/>
</location>
</feature>
<feature type="region of interest" description="EBD domain" evidence="9">
<location>
<begin position="733"/>
<end position="876"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="577"/>
<end position="958"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="252"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="158"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC and autocatalysis" evidence="8 18 23 34 36 37 38 39">
<location>
<position position="284"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="38">
<location>
<position position="518"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="724"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="38">
<location>
<position position="827"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="10">
<location>
<position position="839"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="38">
<location>
<position position="859"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="38">
<location>
<position position="872"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="881"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_037284" evidence="42">
<original>M</original>
<variation>MLEARPPRTQGSDAAGAAAGRGLRALLLSLTAAAGIWGSMGERSAYQRLAGGEEGPQRLGGGRM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008655" evidence="43">
<original>LYLGNPMDPPDLLSVELSTSRPPQHLGGVKKPTYDPVSEDQDPL</original>
<variation>CPFSAFSPGHPPAETCGQVLWTGRREACASDPRLHPVSSRTKGL</variation>
<location>
<begin position="485"/>
<end position="528"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_037285" evidence="42">
<original>K</original>
<variation>KREPPPRPPQPAFFTQ</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008656" evidence="43">
<location>
<begin position="529"/>
<end position="1038"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_037286" evidence="42">
<location>
<begin position="965"/>
<end position="994"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates; no effect on subcellular localization to perinuclear region." id="VAR_032792" evidence="25 33">
<original>R</original>
<variation>L</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56036945." id="VAR_032793" evidence="25">
<original>K</original>
<variation>R</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian mucinous carcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region; dbSNP:rs113498671." id="VAR_032794" evidence="25 33">
<original>R</original>
<variation>Q</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3747673." id="VAR_032795" evidence="25">
<original>R</original>
<variation>W</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56161912." id="VAR_032796" evidence="25">
<original>T</original>
<variation>M</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian endometrioid cancer sample; somatic mutation; undergoes autoactivation and causes phosphorylation on Y-284 leading to activation of AKT1; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on catalytic activity itself as the purified kinase domain has activity in vitro comparable to wild-type protein; no effect on subcellular localization to perinuclear region; dbSNP:rs970946035." id="VAR_032797" evidence="25 33 34">
<original>E</original>
<variation>K</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region." id="VAR_032798" evidence="25 33">
<original>M</original>
<variation>I</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35759128." id="VAR_032799" evidence="25">
<original>P</original>
<variation>S</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with childhood-onset epilepsy; unknown pathological significance; loss of interaction with NEDD4 and NEDD4L; increased protein abundance; dbSNP:rs201407161." id="VAR_076966" evidence="40">
<original>V</original>
<variation>M</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56260729." id="VAR_032800" evidence="17 25">
<original>P</original>
<variation>L</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs57872314." id="VAR_032801" evidence="25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3749333." id="VAR_057115">
<original>P</original>
<variation>L</variation>
<location>
<position position="802"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13433937." id="VAR_032802" evidence="25">
<original>R</original>
<variation>H</variation>
<location>
<position position="1038"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on autophosphorylation at Y-284." evidence="33">
<original>L</original>
<variation>Q</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation at Y-284." evidence="22 33">
<original>K</original>
<variation>R</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on autophosphorylation at Y-284." evidence="33">
<original>L</original>
<variation>Q</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased autophosphorylation at Y-284." evidence="33">
<original>V</original>
<variation>R</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constantly active kinase." evidence="22">
<original>L</original>
<variation>F</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH08884." ref="4" evidence="44">
<original>G</original>
<variation>V</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH08884." ref="4" evidence="44">
<original>TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR</original>
<variation>PPWRDISASSSTQFPHAVPCFPTSLLAKLLLRHSVPASSREIKLVSILC</variation>
<location>
<begin position="304"/>
<end position="352"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH08884." ref="4" evidence="44">
<location>
<begin position="353"/>
<end position="1038"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA53570." ref="1" evidence="44">
<original>A</original>
<variation>P</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA53570." ref="1" evidence="44">
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA53570." ref="1" evidence="44">
<original>PRA</original>
<variation>AG</variation>
<location>
<begin position="838"/>
<end position="840"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="118"/>
<end position="120"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="126"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="140"/>
<end position="146"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="152"/>
<end position="159"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="171"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="192"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="202"/>
<end position="206"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="213"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="226"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="255"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="258"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="265"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="273"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="294"/>
<end position="296"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="299"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="306"/>
<end position="308"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="309"/>
<end position="324"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="330"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="336"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="358"/>
<end position="367"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="372"/>
<end position="374"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="378"/>
<end position="387"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="412"/>
<end position="417"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="423"/>
<end position="432"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="435"/>
<end position="439"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="440"/>
<end position="443"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="449"/>
<end position="451"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="484"/>
<end position="486"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CF4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1U46"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EQP"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EQR"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HZR"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HZS"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O54967"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10587647"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10652228"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278436"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15308621"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16137687"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247015"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16257963"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16288044"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16472662"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17038317"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17494760"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18262180"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18435854"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18477472"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18993068"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19144635"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19815557"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20110370"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20333297"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20383201"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20623637"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20979614"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21169560"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21309750"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23686771"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8497321"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<sequence length="1038" mass="114569" checksum="74A1980665BC3E6B" modified="2009-05-05" version="3">
MQPEEGTGWLLELLSEVQLQQYFLRLRDDLNVTRLSHFEYVKNEDLEKIGMGRPGQRRLW
EAVKRRKALCKRKSWMSKVFSGKRLEAEFPPHHSQSTFRKTSPAPGGPAGEGPLQSLTCL
IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA
MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM
GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE
SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI
YNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLHIQMNDVITVIEGRA
ENYWWRGQNTRTLCVGPFPRNVVTSVAGLSAQDISQPLQNSFIHTGHGDSDPRHCWGFPD
RIDELYLGNPMDPPDLLSVELSTSRPPQHLGGVKKPTYDPVSEDQDPLSSDFKRLGLRKP
GLPRGLWLAKPSARVPGTKASRGSGAEVTLIDFGEEPVVPALRPCAPSLAQLAMDACSLL
DETPPQSPTRALPRPLHPTPVVDWDARPLPPPPAYDDVAQDEDDFEICSINSTLVGAGVP
AGPSQGQTNYAFVPEQARPPPPLEDNLFLPPQGGGKPPSSAQTAEIFQALQQECMRQLQA
PAGSPAPSPSPGGDDKPQVPPRVPIPPRPTRPHVQLSPAPPGEEETSQWPGPASPPRVPP
REPLSPQGSRTPSPLVPPGSSPLPPRLSSSPGKTMPTTQSFASDPKYATPQVIQAPGPRA
GPCILPIVRDGKKVSSTHYYLLPERPSYLERYQRFLREAQSPEEPTPLPVPLLLPPPSTP
APAAPTATVRPMPQAALDPKANFSTNNSNPGARPPPPRATARLPQRGCPGDGPEAGRPAD
KIQMAMVHGVTTEECQAALQCHGWSVQRAAQYLKVEQLFGLGLRPRGECHKVLEMFDWNL
EQAGCHLLGSWGPAHHKR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>